Peter Rahmer - Chief Corporate Development Officer at Relay Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Corporate Development Officer
Stock Symbol
RLAY on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Peter Rahmer - trading volume in the past year for Relay Therapeutics, Inc.

Holdings reported by Peter Rahmer for Relay Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 402K $1.14M $2.84 Mar 27, 2025 Direct
Stock Option (Right to Buy) 275K Jan 10, 2025 Direct Common Stock

Transactions reported by Peter Rahmer for Relay Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.